R. Kuse et al., AUTOMATED RETICULOCYTE COUNTING FOR MONITORING PATIENTS ON CHEMOTHERAPY FOR ACUTE LEUKEMIAS AND MALIGNANT-LYMPHOMAS, Clinical and laboratory haematology, 18, 1996, pp. 39-43
Flow cytometric reticulocyte counting including their maturation fract
ions was performed with a Sysmex R-3000(TM) automated analyser during
follow-up after induction and/or consolidation with combination chemot
herapy in patients with acute leukaemias (AL, n = 39; 58 courses) and
malignant lymphomas (ML, n = 21; 29 courses). The ML patients received
granulocyte colony stimulating factor (G-CSF) in addition after chemo
therapy. During the leucopenic phase only reticulocytes of low fluores
cence ratio (LFR) at extremely low concentration (< 10 x 10(9)/l) were
found. After a median interval of 17 days (range 8-43), the middle fl
uorescence fraction (MFR) began to rise, preceding high fluorescence r
atio (HFR) reticulocytes by a median of 1 day in AL patients with comp
lete or partial remission, In ML patients, MFR and HFR reticulocytes a
ppeared more often simultaneously after a median internal of only 11 d
ays (range 8-15) and increased faster during the first week of marrow
recovery showing a pattern different from AL. Granulocytes passed the
critical limit of 0.5 x 10(9)/l at a median of 5 days after appearance
of MFR reticulocytes in AL but in ML on the same day as MFR and HFR (
day 0). The absolute reticulocyte concentration reached the lower limi
t of the reference range after about 10 days in AL. Thus, finding MFR
and, to a lesser extent, HFR at very low cell concentrations, may serv
e as sensitive early indicators of marrow recovery after chemotherapy
and are much more sensitive parameters than the absolute reticulocyte
concentration. The higher median values for reticulocytes (total, HFR
and MFR) after G-CSF therapy suggests that G-CSF is not lineage specif
ic and may also stimulate erythroid precursor cells.